AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
United States Diane Tang Liu Brian Berman Aiviva Biopharma University Of Miami Miller School Medicine Aiviva Biopharma Inc
Source: medindia.net